OWA
GMAB icon

One Wealth Advisors’s Genmab GMAB Stock Holding History

One Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Sell
13,683
-137
-1% -$3.64K 0.04% 223
2026
Q1 		$371K Buy
13,820
+133
+1% +$3.99K 0.05% 215
2025
Q4 		$422K Buy
13,687
+5,629
+70% +$175K 0.05% 194
2025
Q3 		$247K Buy
+8,058
New +$196K 0.03% 269
2024
Q4 		– Sell
-10,270
Closed -$250K – 267
2024
Q3 		$250K Sell
10,270
-4
-0% -$107 0.04% 229
2024
Q2 		$272K Buy
10,274
+253
+3% +$7.17K 0.06% 173
2024
Q1 		$300K Buy
+10,021
New +$294K 0.05% 176

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

One Wealth Advisors's GMAB Position: Q2 2026 in Review

One Wealth Advisors reduced its Genmab (GMAB) stake by 0.99% in Q2 2026, selling an estimated $3.64K and leaving 13,683 shares worth $376K. The position accounts for 0.04% of the portfolio, ranked #223.

One Wealth Advisors first reported a position in GMAB in Q1 2024 and has held it in 7 quarters since. The position peaked at $422K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • One Wealth Advisors held 13,683 shares of Genmab worth $376K as of Q2 2026.
  • One Wealth Advisors sold 137 Genmab shares in Q2 2026, an estimated $3.64K.
  • Genmab made up 0.04% of One Wealth Advisors's portfolio in Q2 2026, its #223 holding.
  • One Wealth Advisors first reported a position in Genmab in Q1 2024 and has held it in 7 quarters since.
  • One Wealth Advisors's Genmab position peaked at $422K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.